Cytomegalovirus infection risk with alemtuzumab therapy in hematological malignancies: a retrospective cohort study in the non-transplant setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytomegalovirus infection risk with alemtuzumab therapy in hematological malignancies: a retrospective cohort study in the non-transplant setting

Published:2024-07 Issue: Volume: Page:1-8
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

George Joel¹,Mozessohn Lee¹²,Lam Philip W.¹³^ORCID

Affiliation:

1. Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

2. Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

3. Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2371474

Reference33 articles.

1. Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects

2. Tridente G. Alemtuzumab. Adverse Events with Biomedicines. 2013, Chapter 7, pages 81-95, Springer, Milano, Print ISBN: 978-88-470-5312-0 Online ISBN: 978-88-470-5313-7, https://link.springer.com/chapter/10.1007/978-88-470-5313-7_7#citeas.

3. Alemtuzumab: what Is the Secret to Safe Therapy?;Elter T;Clin Adv Hematol Oncol,2011

4. Overview: Cytomegalovirus and the Herpesviruses in Transplantation

5. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP